Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

EPO peptides and anti-EPO antibodies from Behringwerke

Feb. 3, 1998

Newly identified human natural killer cell-activating factor reported by HGS

Feb. 3, 1998

Yeda patents IFN-alpha/beta receptor-neutralizing antibodies

Feb. 3, 1998

BASF presents new ET antagonists

Feb. 3, 1998

New analgesic agents from Gruenenthal

Feb. 3, 1998

Heterocyclic bradykinin antagonists in development at Hoechst Marion Roussel

Feb. 3, 1998

Synthelabo claims mixed and specific dopamine receptor ligands

Feb. 3, 1998

Somatostatin receptor ligands synthesized by Novo Nordisk

Feb. 2, 1998

AMPA receptor antagonists disclosed by Pfizer

Feb. 2, 1998

New anticonvulsants under study at Bristol-Myers Squibb

Feb. 2, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...